NCT06166914
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Detachment, +2 more
- Locations
-
- Faculty of Medicine, Alexandria University Alexandria, Egypt
Clinical trial condition
Proliferative Vitreoretinopathy
Explore clinical trials studying Proliferative Vitreoretinopathy. Study availability and eligibility vary by location and protocol.
20 public trials
2 recruiting studies
Proliferative Vitreoretinopathy trial results
Completed
Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
NCT03727776
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Diseases, +1 more
- Locations
-
- Wilmer Eye Institute, Johns Hopkins Hospital Baltimore, Maryland, United States
NCT02192970
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Detachment, +2 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT04490876
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Detachment, +2 more
- Locations
-
- Centro Oftalmologico Dr Charles Buenos Aires, Buenos Aires F.D., Argentina
NCT01445028
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Diseases, +1 more
- Locations
-
- Wills Eye Institute Philadelphia, Pennsylvania, United States
NCT01995045
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Degeneration, +4 more
- Locations
-
- Emory University Eye Center Atlanta, Georgia, United States
NCT01255293
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
- Locations
-
- Wills Eye Institute Philadelphia, Pennsylvania, United States
NCT00373282
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Detachment, +2 more
- Locations
-
- Hamid Ahmadieh,MD Tehran, Tehran Province, Iran
Completed
The Silicone Study
NCT00000140
- Conditions
- Eye Diseases, Proliferative Vitreoretinopathy, Retinal Detachment, +2 more
- Locations
-
Not specified
Active, Not Recruiting
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
NCT05660447
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +14 more
- Locations
-
- Wills Eye Physicians - Mid Atlantic Retina Philadelphia, Pennsylvania, United States